Facebook YouTube Twitter Linkedin
Facebook YouTube Twitter Linkedin

Alzheimer’s Association International Conference 2016

Cambridge Cognition will be demonstrating the latest neurotechnology at the Alzheimer's Association International Conference (AAIC) from July 22-23rd in Toronto, Canada. Our expert neuroscientists will present data using CANTAB for measuring change over time in MCI, as well as, how wearable devices could be used to measure cognition, mood and behaviour.

The team will be showcasing Cognition Kit™ and Cambridge Cognition's latest neurotechnology products enabling researchers, biotech and pharmaceutical companies to deliver success in clinical trials from patient recruitment and retention, through all phases of development and in post-marketing and patient engagement.

Join the team or a CANTAB researcher in one of the sessions below or find us on booth #823 to see the latest in neurotechnology from CANTAB.







Saturday 23rd

3:40 - 4:40 PM

Commercialization of Technology Applications for Alzheimer’s Expert Panel


High-Frequency Monitoring of Cognition, Mood and Behaviour Using Commercially Available Wearable Devices

Francesca Cormack, PhD, Director of Research & Innovation





Sunday 24th

1:00 - 2:00 PM


Not Yet MCI: How to Detect Subtle Cognitive Impairment?

Elena Chipi, University of Perugia, Italy




Monday 25th

1:00 - 2:00 PM

CSF b-Amyloid and APOE ɛ4 Related Decline in Episodic Memory over 12 months measured using the CANTAB in individuals with amnestic MCI: Results from the European-ADNI study

Rosemary Abbott, PhD, Principal Statistical Analyst





Monday 25th

1:00-2:00 PM

Longitudinal Changes in Visual Memory in Mild Cognitive Impairment Versus Normal Aging in People with Subjective Cognitive Complains

Onesimo Juncos-Rabadan,

University of Santiago de Compostela



Monday 25th

2:00-2:15 PM


Cognitive Composite Measures in Amnestic MCI By Different Amyloid/Tau Pathology

Marina Boccardi,

IRCCS Istituto Centro San Giovanni di Dio-Fatebenefratelli, Brescia, Italy





Tuesday 26th


9:30 - 10:30 AM

The Predictive Utility of Cognitive Measures at Screening for Determination of CSF Abeta (1-42) Status in Subjects with Prodromal Alzheimer's Disease: data from the SCarletRoAD trial

Kenton Zavitz, PhD, Director of Clinical Affairs



Tuesday 26th

1:00 - 2:00 PM

Differential Effects of APOE and CSF Amyloid on Memory Impairment in Individuals with Amnestic MCI Using the Cantab Cognitive Battery : Results from the European-ADNI Study

Rosemary Abbott, PhD, Principal Statistical Analyst



Tuesday 26th

2:00 - 3:30 PM

Changes to Validity of Online Cognitive Assessment in Young and Older Adults: A Comparison to Supervised Testing Using the CANTAB Battery

Francesca Cormack, PhD, Director of Research & Innovation




Exhibit hall

On booth #823 Cambridge Cognition staff will be demonstrating the latest Cognitive Assessment Technology.

Product showcase

We will be premiering a number of cognitive assessment products for assessment of cognitive function from pre-symptomatic to mild to moderate Alzheimer's disease.

For pharmaceutical research

CANTAB Recruit

Designed to accelerate the recruitment process in clinical trials and reduce costly on-site screen failure.

CANTAB Connect

Test batteries for Prodromal and Mild to Moderate Alzheimer’s disease to reliably assess cognition when developing treatments and interventions.

For academic research

CANTAB Connect Research

Our Prodromal and Mild to Moderate Alzheimer’s batteries provide a rapid and reliably sensitive cognitive assessment system for developing treatments and interventions.



For healthcare

Cognition Kit™

Daily tracking of patient health and wellbeing.


A short, sensitive iPad assessment of visuospatial episodic memory, functional status and mood to detect mild cognitive impairment in primary care and help doctors identify the earliest signs of Alzheimer’s disease.  


Join us on booth #823 to find out more.

Meet our AAIC team


 Myra Richley - Director of Pharmaceutical Business Development

 Francesca Cormack, PhD, Director of Research & Innovation

 Kenton Zavitz, PhD, Director Of Clinical Affairs

 Rosemary Abbott, PhD, Principal Statistical Analyst

 Deanna Friedrich - Sales Director

 Anna Jackson - Healthcare Business Manager

 Lizzie Remfry - Research & Biotech Business Manager


For more information on any of the above contact us now or join us at AAIC 2016 on booth #823